immunity and vaccines for exam 3

66
SO.... HOW DO YOU FIGHT BACK? Monday, February 27, 2012

Upload: marilen-parungao

Post on 12-May-2015

1.208 views

Category:

Technology


1 download

TRANSCRIPT

Page 1: Immunity and vaccines for exam 3

SO.... HOW DO YOU FIGHT

BACK?

Monday, February 27, 2012

Page 2: Immunity and vaccines for exam 3

HOST FACTORS: WHAT YOU DO TO FIGHT INFECTIONSImmune System Overview

Factors that affects the immune status of the host

age, nutrition, hygiene, etc

Monday, February 27, 2012

Page 3: Immunity and vaccines for exam 3

BEFORE THE IMMUNITY...

Monday, February 27, 2012

Page 4: Immunity and vaccines for exam 3

Monday, February 27, 2012

Page 5: Immunity and vaccines for exam 3

OVERVIEW: HOW WE FIGHT INFECTIONS...

www.youtube.com/watch?v=T_4TrNRa3v8Monday, February 27, 2012

Page 6: Immunity and vaccines for exam 3

THE CELLS...

Monday, February 27, 2012

Page 7: Immunity and vaccines for exam 3

INNATE HUMORAL : THE COMPLEMENT

Monday, February 27, 2012

Page 8: Immunity and vaccines for exam 3

THE COMPLEMENT SYSTEM & THEIR FUNCTION

Monday, February 27, 2012

Page 9: Immunity and vaccines for exam 3

INNATE CELLULAR

MONOCYTES

dendritic cells (antigen presenting cells)

macrophages (ingest foreign cells)

NATURAL KILLER CELLS

releases proteins to kill foreign cells

GRANULOCYTES

mast cells (releases histamines during allergic reactions)

neutrophils, eosinophil, basophils

Monday, February 27, 2012

Page 10: Immunity and vaccines for exam 3

DENDRITIC CELLS & ANTIGEN PRESENTATION

Monday, February 27, 2012

Page 11: Immunity and vaccines for exam 3

MACROPHAGES

Monday, February 27, 2012

Page 12: Immunity and vaccines for exam 3

NATURAL KILLER CELLS

Monday, February 27, 2012

Page 13: Immunity and vaccines for exam 3

MAST CELLS

Monday, February 27, 2012

Page 14: Immunity and vaccines for exam 3

THE PHILS...

NEUTROPHILS

EOSINOPHILS

BASOPHILS

INFLAMMATION

Monday, February 27, 2012

Page 15: Immunity and vaccines for exam 3

ADAPTIVE HUMORAL

Monday, February 27, 2012

Page 16: Immunity and vaccines for exam 3

ADAPTIVE HUMORAL

Monday, February 27, 2012

Page 17: Immunity and vaccines for exam 3

ADAPTIVE HUMORAL

Monday, February 27, 2012

Page 18: Immunity and vaccines for exam 3

Monday, February 27, 2012

Page 19: Immunity and vaccines for exam 3

ADAPTIVE CELLULAR

B cells

plasma cells = differentiates to antibodies

memory cells = for secondary exposure to antigens

Th

helpers

activates humoral response (immune cells)

Tc

cytotoxic

kills and clears

Monday, February 27, 2012

Page 20: Immunity and vaccines for exam 3

B CELLS

Monday, February 27, 2012

Page 21: Immunity and vaccines for exam 3

T HELPER CELL

Monday, February 27, 2012

Page 22: Immunity and vaccines for exam 3

CYTOTOXIC T CELL

Monday, February 27, 2012

Page 23: Immunity and vaccines for exam 3

MHC CLASSES

A. Which T cell will perform

B. Which pathogen type

Intracellular ExtracellularMonday, February 27, 2012

Page 24: Immunity and vaccines for exam 3

INFECTION BY BACTERIA

Bacterial Infections Are Eliminated By Humoral Immunity

Exception: intracellular bacteria Ex. TB

Antibodies Eliminate Bacteria Or Bacterial Toxins

Opsonization Of Bacteria

Neutralization Of Toxins

Exotoxins (Ex. Diptheria)

Endotoxins (Ex. LPS)

Lysis Of Bacteria Thru Complement Pathway

Bacteria Enter Host Thru

Respiratory Tract, GI Tract, Genitourinary Tract, Skin

Monday, February 27, 2012

Page 25: Immunity and vaccines for exam 3

Monday, February 27, 2012

Page 26: Immunity and vaccines for exam 3

EVASION BY BACTERIA

Some Bacteria Have Pili

Some Bacteria Secrete Adhesion Molecules (Bordetella pertussis)

Immune System Response To Attachment Is IgA

Prevents Attachment

Some Bacterial Evade IgA Thru Proteases That Decrease ½ Life Of IgA

Ex. Haemophilus influenzae

Some Bacteria Avoid Phagocytosis By Surrounding Themselves In A Polysaccharide Capsule. Ex. Streptococcus pneumoniae

Monday, February 27, 2012

Page 27: Immunity and vaccines for exam 3

OVERZEALOUS IMMUNE SYSTEM NOT BENEFICIALBacterial Septic Shock

Predominant Cytokines Involved: IL-1 and TNF-α

Source: MΦ

Intracellular Bacteria Cause Granulomas

Extensive Tissue Damage

Ex. Tuberculosis

In Tuberculosis, MΦ Ingest MTB But Cannot Digest It

Eventually Burst - Releasing Bacilli

MΦ And TH1 Cells Form Granulomatous Lesion, Containment+Destruction Of Healthy Tissue

INF-γ and IL-12 Are Crucial In Eliminating Pathogen

Monday, February 27, 2012

Page 28: Immunity and vaccines for exam 3

Monday, February 27, 2012

Page 29: Immunity and vaccines for exam 3

INFECTION BY VIRUSES

The Immune Response Against Virus Is Primarily Mediated Thru Interferons

Double stranded RNA induces production of IFN

Main producers of IFNα and IFNβ are pDCs

TLR-3 (dsRNA); TLR-7 (ssRNA)

Interferons produce an anti-viral state

A state that inhibits viral replication

A state that inhibits viral infection

Monday, February 27, 2012

Page 30: Immunity and vaccines for exam 3

Monday, February 27, 2012

Page 31: Immunity and vaccines for exam 3

Antibody Protection Against Viruses

Antibodies Bind To Viral Surface Antigens

Protect against re-infection

Huge amounts of secretory IgA in lumen block viral attachment

Viral Entry Into Cells Is Mediated Thru Receptors

Influenza virus binds to sialic acid on glycoproteins

Rhinovirus binds to ICAMs

If Receptor Is Blocked, Infection Is Blocked

Oral Polio vaccine Relies On IgA Production

Monday, February 27, 2012

Page 32: Immunity and vaccines for exam 3

Antibody Protection Against Viruses

Monday, February 27, 2012

Page 33: Immunity and vaccines for exam 3

Antibodies Are Efficient In Preventing Infection

Antibody Protection Against Viruses

Monday, February 27, 2012

Page 34: Immunity and vaccines for exam 3

Antibodies Are Efficient In Preventing Infection

Once Infection Has Occurred, Only Cell Mediated Immunity Can Eliminate Infected Cells

Antibody Protection Against Viruses

Monday, February 27, 2012

Page 35: Immunity and vaccines for exam 3

Antibodies Are Efficient In Preventing Infection

Once Infection Has Occurred, Only Cell Mediated Immunity Can Eliminate Infected Cells

Examples Of Cell Mediated Immunity

TH1, CTL Are the major participants

Antibody Protection Against Viruses

Monday, February 27, 2012

Page 36: Immunity and vaccines for exam 3

Antibody Protection Against Viruses

Monday, February 27, 2012

Page 37: Immunity and vaccines for exam 3

TH1 Produce IFN-γ, IL-2, and TNF-α

IL-2 expands CTL-P

IFN-γ induces antiviral state

IL-2 and IFN-γ activate NK cells (first line of defense)

Antibody Protection Against Viruses

Monday, February 27, 2012

Page 38: Immunity and vaccines for exam 3

TH1 Produce IFN-γ, IL-2, and TNF-α

IL-2 expands CTL-P

IFN-γ induces antiviral state

IL-2 and IFN-γ activate NK cells (first line of defense)

CTL (cytotoxic lymphocytes)

Peaks 7-10 days post infection

Eliminate virally infected cells

Antibody Protection Against Viruses

Monday, February 27, 2012

Page 39: Immunity and vaccines for exam 3

VACCINES & VPD

Monday, February 27, 2012

Page 40: Immunity and vaccines for exam 3

THERE ARE 2 WAYS TO PROTECT YOURSELF...A.

B.

Monday, February 27, 2012

Page 41: Immunity and vaccines for exam 3

Monday, February 27, 2012

Page 42: Immunity and vaccines for exam 3

Monday, February 27, 2012

Page 43: Immunity and vaccines for exam 3

Monday, February 27, 2012

Page 44: Immunity and vaccines for exam 3

Monday, February 27, 2012

Page 45: Immunity and vaccines for exam 3

Monday, February 27, 2012

Page 46: Immunity and vaccines for exam 3

Monday, February 27, 2012

Page 47: Immunity and vaccines for exam 3

Monday, February 27, 2012

Page 48: Immunity and vaccines for exam 3

Monday, February 27, 2012

Page 49: Immunity and vaccines for exam 3

Monday, February 27, 2012

Page 50: Immunity and vaccines for exam 3

Monday, February 27, 2012

Page 51: Immunity and vaccines for exam 3

Monday, February 27, 2012

Page 52: Immunity and vaccines for exam 3

Monday, February 27, 2012

Page 53: Immunity and vaccines for exam 3

BACTERIAL VACCINESBacteria Disease Antigen Efficacy

Streptococcus pneumoniae

Pneumonia Capsular polysaccharide

85%

Neisseria meningitidis

meningitis Capsular polysaccharide

85%

Hemophilus influenzae

meningitis Capsular polysaccharide

85%

Corynebacterium diphtheriae

Diphtheriae Toxoid >90%

Clostridium tetani tetanus Toxoid >90%

Bordetella pertussis Whooping cough Killed organism >90%

Mycobacterium bovis (BCG)

Tuberculosis Live attenuated 0 – 70 %

Salmonella typhi Typhoid fever Killed/Live attenuated

80%

Monday, February 27, 2012

Page 54: Immunity and vaccines for exam 3

IMMUNIZATION FOR INFANTSVaccine Reason for Immunization

BCG Given at the earliest possible age protects against the possibility of infection from

family members

DPT Early start with DPT reduces chance of severe pertussis

OPV Protection against polio increased the earlier the OPV is given

Hepatitis B Early start of HBV vaccination reduces chance of being infected and becoming a

carrier

Measles At least 80% of measles can be prevented by immunization at this age

Monday, February 27, 2012

Page 55: Immunity and vaccines for exam 3

SCHEDULEAge Diseases to be immunized against

Birth Tuberculosis

6 weeks DPT; Polio; HBV

10 weeks DPT; Polio; HBV

14 weeks DPT; Polio; HBV

9 months Measles

Monday, February 27, 2012

Page 56: Immunity and vaccines for exam 3

SIDE EFFECTS OF BCG30 minutes wheal disappears2 weeks: a small red tender swelling 10 cm appears

3 weeks: swelling becomes a small abscess which then ulcerates

12 weeks: course from vaccination to healing & scarification

SIDE EFFECTS:1. Koch’s phenomenon- an acute

inflammatory reaction appearing within 2-4 days of vaccination

2. Deep abscess at vaccination site – due to subcutaneous or deeper injection (I & D)

3. Indolent ulceration- an ulcer which persists after 12 weeks or > 10cm deep (Tx –INH powder)

4. Lymph node enlargementMonday, February 27, 2012

Page 57: Immunity and vaccines for exam 3

SIDE EFFECTS DPTSIDE EFFECTS:Fever: many children develop fever after injection , lasting only one day; fever that lasts more than 24 hours after a dose of DPT is not due to the vaccine but to other causes

Local Soreness: Pain or swelling at injection site

Advice/ Management

Antipyretic or tepid sponge bath

Reassure mother that swelling needs no treatment and will disappear within 3-4 days

Monday, February 27, 2012

Page 58: Immunity and vaccines for exam 3

SIDE EFFECTS DPTSIDE EFFECTS:Abscess: If this appears a week or more after the injection, it is due to wrong technique. Either the vaccine was not injected deep enough or the needed was not sterile

Convulsions: Very rare; occurs more in >3 months; usually due to pertussis component of the vaccine

Advice/ Management

Incision and drainage is necessary

If convulsions occur, give proper management and do not continue the normal course

Monday, February 27, 2012

Page 59: Immunity and vaccines for exam 3

SIDE EFFECTS MEASLES VACCINE

SIDE EFFECTS:Fever and rash: Children may develop fever after 5-7 days from the time of vaccination

Fever lasts only from 1-3 days.Sometimes a mild rash appears

Advice/ Management

Reassure the mother and advise antipyretic for the child

Monday, February 27, 2012

Page 60: Immunity and vaccines for exam 3

TETANUS TOXOIDVaccine Minimum age/

intervalPercent

protectedDuration of protection

TT1 As early as possible during pregnancy

TT2 At least 4 weeks later 80% * Infants born to the mother protected from neonatal tetanus; 3 years protection to mother

TT3 At least 6 months later 95% * Infants protected; 5 years protection to mother

TT4 At least one year later 99% * Infants protected; 10 years protection to mother

TT5 At least one year later 99% Lifetime protection for mother; * all infants born to that mother will be protected

Monday, February 27, 2012

Page 61: Immunity and vaccines for exam 3

VACCINES AND POLIO ERADICATION EFFORTS (smallpox as model)

Parungao-Balolong 2011Monday, February 27, 2012

Page 62: Immunity and vaccines for exam 3

MEASLES & HERD

IMMUNITY

thepaltrysapien.com

Monday, February 27, 2012

Page 63: Immunity and vaccines for exam 3

EMERGING & RE-EMERGING INFECTIONS

Monday, February 27, 2012

Page 64: Immunity and vaccines for exam 3

EMERGING & RE-EMERGING INFECTIONS

Monday, February 27, 2012

Page 65: Immunity and vaccines for exam 3

PUBLIC HEALTH PLANNING & INTERVENTION

Disaster and Outbreak Preparedness

Accessibility to Intervention and Good Clinical Management

Environmental Sanitation and Hygiene

Research: Diagnostics, Therapy and Pathogenic Mechanisms

Surveillance and Prevention Control Programs

Health Promotion and Awareness Ads and Campaigns

Monday, February 27, 2012

Page 66: Immunity and vaccines for exam 3

END OF BIO 120 LECTURES

Monday, February 27, 2012